About this trial
To evaluate whether the measurement of urinary estrone glucuronide and luteinizing hormone (LH) concentrations with an at-home device is correlated with serum hormone levels within a natural cycle frozen embryo transfer protocol.
The hypothesis is that home urinary monitoring can reliably detect the LH surge and serve as a trigger for timing the FET. Results of this study may ultimately lead to change in clinical practice by reducing the number of clinic visits for serum monitoring, offering a more convenient, time and cost saving method of detection of LH surge. If the proposed protocol were feasible and widely accepted by patients, this would prompt the wide adoption of a less invasive but equally as effective FET protocol.
Eligibility criteria
Qualifiers
All patients scheduled for a natural cycle frozen embryo transfer
Agree to participate in the research study
Disqualifiers
There are no exclusions
Trial design
Treatments tested in this trial
- MIRA Device
Treatment groups
Sponsors and collaborators
Ottawa Fertility Centre
Lead sponsor
Quanovate Tech Inc.
Collaborator